Group A Streptococcus Without Sore Throat in Adults
If an adult does not have a sore throat, they do not have Group A Streptococcal pharyngitis and should not be tested or treated for it. The absence of pharyngeal symptoms excludes the diagnosis of streptococcal pharyngitis, which is the primary indication for GAS testing and treatment in adults 1.
Diagnostic Framework
The IDSA guidelines emphasize that GAS pharyngitis diagnosis requires pharyngeal symptoms 1. The guideline explicitly states that "the signs and symptoms of GAS and nonstreptococcal pharyngitis overlap so broadly that accurate diagnosis on the basis of clinical grounds alone is usually impossible," but this assumes pharyngitis is present 1. Without sore throat:
- Do not perform throat culture or rapid antigen detection test - these tests are only indicated when pharyngitis symptoms exist
- Do not prescribe antibiotics empirically - this contributes to antimicrobial resistance without clinical benefit 1
Alternative GAS Manifestations to Consider
While pharyngitis is the most common GAS presentation requiring treatment, adults can rarely present with other GAS manifestations:
Skin and Soft Tissue Infections
- Impetigo, cellulitis, or erysipelas may occur without pharyngeal involvement 2
- These require clinical diagnosis based on skin findings, not throat symptoms
- Treatment follows different protocols than pharyngitis
Invasive GAS Disease
- Necrotizing fasciitis, bacteremia, or toxic shock syndrome present with systemic illness 3
- These are medical emergencies with fever, hypotension, and organ dysfunction
- Diagnosis requires blood cultures or tissue cultures, not throat swabs
Uncommon Systemic Manifestations
One case report describes an adult with arthralgia, rash, and oral ulcers from GAS, but notably this patient had a sore throat as the primary symptom 4. Even in this atypical presentation, pharyngeal symptoms were present.
Clinical Pitfalls to Avoid
Do not test asymptomatic carriers. The guidelines stress that 20-30% of children and fewer adults are asymptomatic GAS carriers 1. Testing without pharyngeal symptoms will identify carriers who:
- Do not benefit from treatment
- Are not at risk for acute rheumatic fever from their carrier state
- Will be unnecessarily exposed to antibiotic adverse effects
Do not confuse prevention strategies with individual diagnosis. Recent evidence shows that even aggressive throat swabbing and antibiotic treatment of pharyngitis prevents only 1-3% of invasive GAS cases, with a number needed to treat of 12,000-110,000 5. This reinforces that GAS treatment is for symptomatic pharyngitis, not population-level invasive disease prevention.
When to Reconsider
If the patient develops:
- Sore throat - then proceed with standard pharyngitis evaluation per IDSA guidelines 1
- Skin lesions - evaluate and culture the skin lesions directly
- Systemic illness - obtain blood cultures and consider invasive GAS disease
The absence of pharyngeal symptoms definitively excludes the indication for GAS pharyngitis testing and treatment in adults.